Erdafitinib
| Erdafitinib | |
|---|---|
| Term | Erdafitinib |
| Short definition | Erdafitinib (ER-duh-FIH-tih-feather) A drug used to treat adults with urothelial cancer (a type of bladder or urinary tract cancer) that is locally advanced or has spread and certain Mutations (changes) in the tumor have FGFR3 or FGFR2 gene or a fusion gene involving these genes. It is used in patients whose cancer has gotten worse during or after treatment with at least one type of platinum chemotherapy. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Erdafitinib - (pronounced) (ER-duh-FIH-tih-feather) A drug used to treat adults with urothelial cancer (a type of bladder or urinary tract cancer) that is locally advanced or has spread and certain Mutations (changes) in the tumor have FGFR3 or FGFR2 gene or a fusion gene involving these genes. It is used in patients whose cancer has gotten worse during or after treatment with at least one type of platinum chemotherapy. It is also being studied in the treatment of other types of cancer. Erdafitinib blocks FGFR and other proteins that can help prevent cancer cells from growing and kill them. It's a type of tyrosine kinase inhibitor. Also called Balversa
External links
- Medical encyclopedia article on Erdafitinib
- Wikipedia's article - Erdafitinib
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski